Earl S Ford1, David M Mannino2, Anne G Wheaton3, Wayne H Giles3, Letitia Presley-Cantrell3, Janet B Croft3. 1. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: eford@cdc.gov. 2. Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, KY. 3. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: National spirometric surveillance data in the United States were last collected during 1988-1994. The objective of this study was to provide current estimates for obstructive and restrictive impairment of lung function and to examine changes since 1988-1994. METHODS: We used data from 14,360 participants aged 20 to 79 years from the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and 9,024 participants from NHANES 2007-2010. Spirometry was conducted using the same spirometers and generally similar protocols. RESULTS: During 2007-2010, 13.5% (SE, 0.6) of participants had evidence of airway obstruction (FEV1/FVC < 0.70): 79.9% of adults had normal lung function, 6.5% had a restrictive impairment, 7.5% had mild obstruction, 5.4% had moderate obstruction, and 0.7% had severe obstruction. Although the overall age-adjusted prevalence of any obstruction did not change significantly from 1988-1994 (14.6%) to 2007-2010 (13.5%) (P = .178), significant decreases were noted for participants aged 60 to 79 years and for Mexican Americans. The prevalence of current smoking remained high among participants with moderate (48.4%) and severe (37.9%) obstructive impairments. A significant decline in current smoking occurred only among those with normal lung function (P < .05). CONCLUSION: Spirometry revealed little change in the prevalence of any obstructive and restrictive impairment in lung function during 2007-2010, compared with 1988-1994.
BACKGROUND: National spirometric surveillance data in the United States were last collected during 1988-1994. The objective of this study was to provide current estimates for obstructive and restrictive impairment of lung function and to examine changes since 1988-1994. METHODS: We used data from 14,360 participants aged 20 to 79 years from the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and 9,024 participants from NHANES 2007-2010. Spirometry was conducted using the same spirometers and generally similar protocols. RESULTS: During 2007-2010, 13.5% (SE, 0.6) of participants had evidence of airway obstruction (FEV1/FVC &lt; 0.70): 79.9% of adults had normal lung function, 6.5% had a restrictive impairment, 7.5% had mild obstruction, 5.4% had moderate obstruction, and 0.7% had severe obstruction. Although the overall age-adjusted prevalence of any obstruction did not change significantly from 1988-1994 (14.6%) to 2007-2010 (13.5%) (P = .178), significant decreases were noted for participants aged 60 to 79 years and for Mexican Americans. The prevalence of current smoking remained high among participants with moderate (48.4%) and severe (37.9%) obstructive impairments. A significant decline in current smoking occurred only among those with normal lung function (P &lt; .05). CONCLUSION: Spirometry revealed little change in the prevalence of any obstructive and restrictive impairment in lung function during 2007-2010, compared with 1988-1994.
Authors: Zorana J Andersen; Martin Hvidberg; Steen S Jensen; Matthias Ketzel; Steffen Loft; Mette Sørensen; Anne Tjønneland; Kim Overvad; Ole Raaschou-Nielsen Journal: Am J Respir Crit Care Med Date: 2010-09-24 Impact factor: 21.405
Authors: Amir Qaseem; Timothy J Wilt; Steven E Weinberger; Nicola A Hanania; Gerard Criner; Thys van der Molen; Darcy D Marciniuk; Tom Denberg; Holger Schünemann; Wisia Wedzicha; Roderick MacDonald; Paul Shekelle Journal: Ann Intern Med Date: 2011-08-02 Impact factor: 25.391
Authors: Martine Hoogendoorn; Talitha L Feenstra; Rudolf T Hoogenveen; Maureen P M H Rutten-van Mölken Journal: Thorax Date: 2010-08 Impact factor: 9.139
Authors: Mark D Eisner; Nicholas Anthonisen; David Coultas; Nino Kuenzli; Rogelio Perez-Padilla; Dirkje Postma; Isabelle Romieu; Edwin K Silverman; John R Balmes Journal: Am J Respir Crit Care Med Date: 2010-09-01 Impact factor: 21.405
Authors: Bartolomé R Celli; Nicola E Thomas; Julie A Anderson; Gary T Ferguson; Christine R Jenkins; Paul W Jones; Jørgen Vestbo; Katharine Knobil; Julie C Yates; Peter M A Calverley Journal: Am J Respir Crit Care Med Date: 2008-05-29 Impact factor: 21.405
Authors: John L Hankinson; Steven M Kawut; Eyal Shahar; Lewis J Smith; Karen Hinckley Stukovsky; R Graham Barr Journal: Chest Date: 2009-09-09 Impact factor: 9.410
Authors: Jin Hwa Lee; Michael H Cho; Merry-Lynn N McDonald; Craig P Hersh; Peter J Castaldi; James D Crapo; Emily S Wan; Jennifer G Dy; Yale Chang; Elizabeth A Regan; Megan Hardin; Dawn L DeMeo; Edwin K Silverman Journal: Respir Med Date: 2014-08-11 Impact factor: 3.415
Authors: Alejandro A Diaz; Carolyn E Come; David M Mannino; Victor Pinto-Plata; Miguel J Divo; Carol Bigelow; Bartolome Celli; George R Washko Journal: Chest Date: 2014-02 Impact factor: 9.410
Authors: Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita Journal: Am J Kidney Dis Date: 2017-07-26 Impact factor: 8.860
Authors: Fernando J Martinez; MeiLan Han; Nancy Leidy; Barry Make; David M Mannino; Stephen I Rennard; Byron M Thomashow; Barbara P Yawn Journal: Am J Respir Crit Care Med Date: 2018-01-15 Impact factor: 21.405
Authors: Ying Y Zhao; Terri Blackwell; Kristine E Ensrud; Katie L Stone; Theodore A Omachi; Susan Redline Journal: Sleep Date: 2016-07-01 Impact factor: 5.849